Pausing Antiretroviral Treatment Under Structured Evaluation

Condition:   HIV-1-infection Interventions:   Drug: 3BNC117-LS-J;   Drug: 10-1074-LS-J;   Drug: Placebo for 3BNC117-LS-J;   Drug: Placebo for 10-1074-LS-J Sponsors:   AIDS Clinical Trials Group;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials